Introduction
============

The increasing numbers of individuals living with HIV, especially the women as the swiftest--growing group of newly diagnosed HIV, made us interested in preventive measures. Pregnant women are considered as representatives of all women in the child-bearing ages ([@b1-jmehm-2-1], [@b2-jmehm-2-1]).

A high number of the HIV-positive women giving birth each year, so the considerable numbers of HIV-infected infants are added to the population each year. In 2003, the cumulative numbers of death due to prenatally acquired AIDS was estimated to be 5000 in the United States ([@b3-jmehm-2-1]). In addition, long dormancy period prior to launching the disease and the future reflection of epidemiologic studies in AIDS, HIV screening displays a more recent description ([@b4-jmehm-2-1]).

In Iran the most HIV infected patients (75%) are men in the range of 15--49 year which are sexually active group of the society. Lack of access to the high risk women for consultation and testing, the actual number of HIV positive women have not been identified ([@b5-jmehm-2-1]). According to the last population study there are more than 66000 HIV positive in Iran ([@b6-jmehm-2-1]).

Considering the preventive effects of zidovudine during pregnancy in 1994 which can decrease the chance of vertical transmission of HIV, preventive efforts have focused on pregnant women as a target group for HIV testing ([@b7-jmehm-2-1]). Concerning these facts, prevention of mother-to-child transmission (PMTCT) programs launched as worldwide programs. The emergence of new antiretroviral medications and the efficacy of a combination of three highly active drugs, prevention of HIV infection in newborns and treatment of women assigned to be the primary and secondary goals of prevention respectively ([@b8-jmehm-2-1], [@b9-jmehm-2-1]).

The maternal transmission of HIV infection can happen during pregnancy (antepartum), through labor and delivery (intrapartum), and after delivery (postnatal). Antepartum transmission is suggested to be signified as much as 25% to 40% of the cases of maternal transmission and the rest of cases occur during labor and delivery ([@b10-jmehm-2-1]). The risk of maternal transmission can be reduced by techniques which decrease the chance of the interaction between infected maternal blood and fetus ([@b11-jmehm-2-1]).

Postnatal transmission which estimated to account for 44% of newborn cases occurs in setting of breastfeeding ([@b12-jmehm-2-1]). The higher maternal viral load and the lower CD4 cell counts increase the risk of transmission ([@b13-jmehm-2-1]--[@b17-jmehm-2-1]). The risk of vertical transmission of HIV can be reduced as less as 1% by combination anti-retroviral regimens both in mother and newborn six weeks postpartum, in addition to eluding breastfeeding and cesarean section ([@b18-jmehm-2-1]--[@b21-jmehm-2-1]).

Therefore HIV screening during pregnancy and before delivery is the most important step in the aim of preventing disease transmission ([@b22-jmehm-2-1]). Distinguishing HIV-infected pregnant women pave the way of choosing the best treatment option during pregnancy and reduce the risk of vertical transmission as well ([@b22-jmehm-2-1]). Recently, universal testing of all pregnant women is currently recommended and supported by the Canadian Pediatric Society (CPS), the American Academy of Pediatrics (AAP), the Institute of Medicine (IOM), the American College of Obstetricians and Gynecologists (ACOG), and the Society of Obstetricians and Gynecologists of Canada (SOGC) ([@b23-jmehm-2-1]).

In spite of global agreement on the necessity of upraising HIV testing, the most effective way of the action and its quality is on debate in different societies ([@b24-jmehm-2-1]).

In the regions with high HIV prevalence, the voluntary HIV counseling and testing displaced with routine or mandatory testing ([@b25-jmehm-2-1]) that is on debates ([@b26-jmehm-2-1]). The question is that: Is the mandatory testing a moral option in this case and how we get aware of its necessity?

Methods of testing
==================

Previously, the worldwide strategy was based on promoting client-initiated voluntary counseling and testing (VCT) and according to the consent, counseling and confidentiality ([@b27-jmehm-2-1]). Regarding its usefulness in public health and human rights fields, now some health care providers argue about its insufficiency in making the HIV testing more routine ([@b28-jmehm-2-1]).

After a while two other types of HIV testing \[client initiated (voluntary) testing versus provider initiated (mandatory) testing\], were introduced to the health care providers.

A similar division method has divided the HIV testing methods into the other two different types of HIV testing opt-in versus opt-out HIV testing. In opt-in method a comprehensive pre-test counseling and informed consent is provided for women ([@b29-jmehm-2-1]). The rate of accepting the test is related to the quality and quantity of counseling ([@b30-jmehm-2-1]). In the optout method the test is conducted routinely after giving enough information to pregnant women however they have the right to refuse ([@b29-jmehm-2-1]). In the opt-out method the patient should be aware of the risks and benefits of testing, her rights and health care services if the test is positive ([@b22-jmehm-2-1]). The higher screening rate was reported by opt-out testing ([@b30-jmehm-2-1]). It is noteworthy that the mandatory HIV testing is the last option in the high prevalence areas when the other strategies have not provided significant reductions in the rate of vertical transmission.

Ethical view
============

Concerning two types of HIV testing \[client initiated (voluntary) testing versus provider initiated (mandatory) testing\] real conflicts have risen in this issue from ethical and legal points of views.

In 2006, WHO and Joint United Nations Program on HIV/AIDS (UNAIDS) released a guidance for promoting provider-initiated HIV testing and counseling (PITC) in health facilities ([@b31-jmehm-2-1]). The guidance consists on collaboration of medical ethics, clinical, public health and human rights and it highlights the necessity of adjustment according to every country context ([@b32-jmehm-2-1]).

Regarding two types of testing, voluntary versus mandatory testing, in any circumstances the mandatory testing is the most disputable strategy because even in a high standard of expertise, it limits individual autonomy and diminishes patient's privacy. While forbidding screening tests allows more babies to be infected, according to respecting individuals and not consider them as an instrument, such a compelling target-driven authoritative to diagnose the infected women may diminish individuals autonomy ([@b33-jmehm-2-1]).

The conception of complying with the formal permission of health staff in support of testing, time shortage for making decision, and the power of universal routine testing all undervalue patient's autonomy ([@b34-jmehm-2-1]).

Mandatory testing provides an estate in which the moral value of mother is secondary to that of her child and it denies her dignity. Therefore she will lose her control on her future life especially when she is vulnerable and needs essential healthcare measures in the term of safeguarding her pregnancy. Despite of efforts in facilitating HIV testing by Clark in a study in Botswana, prevention strategies did not show significant benefits ([@b35-jmehm-2-1]). In this study Clark consisted more on human rights and the moral frame work.

Confidentiality is another important issue and has to be taken into account while exchanging information between healthcare providers in the purpose of providing the most suitable post-test care. Because of the psychological, social and physical distresses to newly diagnosed HIV-positive pregnant women, the assurance between she and health care providers will be omitted which more endangers effective caring modalities ([@b36-jmehm-2-1]).

Practically, a routine offer of HIV testing may predominantly serve as routine testing. In this regard, pre-test counseling will be forgotten. Therefore the principles of HIV testing (consent, counseling, and confidentiality) will be undermined which disregards human rights ([@b37-jmehm-2-1]).

Limitations of routine screening
================================

There are some obstacles in accepting HIV testing such as horror feeling of adverse consequences, having no concern about its benefit, unawareness of HIV risk, cultural and religious norm, inconvenient testing, lack of privacy in counseling and assurance of confidentiality, fear of isolation, and lack of social support ([@b38-jmehm-2-1]). So there is a little probability that an HIV positive patient gets her results and co-operate for receiving treatment modalities ([@b39-jmehm-2-1]).

The insight of low risk to HIV infection considered as the main reason of prohibiting HIV testing in one former research ([@b40-jmehm-2-1], [@b41-jmehm-2-1]).

Also false positive results in low-risk patients and its outcome is a real concern and it wastes our resources and patients trust. However the rate of false positive results is rare and the harms are minimal. The harms of false-positive HIV testing may consist of elective pregnancy termination, anxiety, discrimination or altered partner relationship. Also false-negative and true-negative test results can cause perpetual unsafe behaviors ([@b42-jmehm-2-1]).

Furthermore the adverse effects of antiretroviral medications on fetus cannot be ignored. HIV positive pregnant women should be acknowledged about the possible risks of drug toxicity for fetus. They have to make decision about their own bodies according to their rights. In addition cesarean section as another preventive modality on vertical transmission does not seem to have a major role as chemoprophylaxis.

Regarding the two major benefits from routine HIV testing in pregnant women (early diagnosis to decrease morbidity and mortality and reducing transmission), HIV testing seems to be cost effective.

Conclusion
==========

Considering the prevalence of HIV infection or risk characterization in each population, we (or authorities) can define a screening strategy. It has to be considered that in risk evaluation, the fear and shame of telling truth is an inhibitory force which may lead to unfair risk evaluation.

One another important issue is the time of initiating drug therapy which the best time is between 15 and 19 weeks of gestation. Therefore HIV screening testing should be performed at the first prenatal visit ([@b43-jmehm-2-1], [@b44-jmehm-2-1]).

Paying enough attention to the UNAIDS declarations such as protecting human rights, both of those vulnerable to infection and those already infected is not only right but also produces positive public health results against HIV.

Concerning the low prevalence of HIV in Iran or considering the low number of the confirmed HIV positive women, the reported percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission by WHO which is as low as 2% ([@b45-jmehm-2-1]) while the declaration of commitment HIV/AIDS of the United Nations General assembly special session on HIV/AIDS consisting on preventive measures for reducing the proportion of infants infected with HIV by 50% by 2010 ([@b46-jmehm-2-1]), and the cultural and religious normative, performing the opt-in HIV testing is highly recommended in pregnant women in Iran. In this regard our policy should be based on the below principles: - High rates of agreement to test can be attained by applicable education and support. Generally the belief of autonomy in decision making should be considered when pregnant women are offered to take HIV testing. They should be excused from social expectations as to what would be best for them and empower them to make decisions by themselves.- The health policy should be based on human rights to guarantee decision making autonomously, a person is not keep in repressed by inner contextual forces like as health care provider or partner compulsion, cultural or religious pressures or fear of future access to social networks and support. The obstetricians visit is a good time for exchanging much information in an acceptable and effective way without reasoning a major concern or signal in the patient. Additional methods such as audiovisual aids and informal education by a nurse counselor or social worker in the clinic may be helpful ([@b47-jmehm-2-1]).

The benefits of performing this screening test in pregnant women will be considerable because it is a fundamental way of reducing the outcome of HIV globally and augmenting human dignity, security and development.
